.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
QuintilesIMS
AstraZeneca
Queensland Health
Merck
Chinese Patent Office
Dow
Cipla
Federal Trade Commission
US Department of Justice

Generated: September 20, 2017

DrugPatentWatch Database Preview

Bretylium tosylate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for bretylium tosylate and what is the scope of bretylium tosylate patent protection?

Bretylium tosylate
is the generic ingredient in four branded drugs marketed by Abbott, Hospira Inc, Intl Medication, B Braun, Hospira, Abraxis Pharm, Baxter Hlthcare, West-ward Pharms Int, Eurohlth Intl Sarl, Astrazeneca, and Luitpold, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for bretylium tosylate.

Summary for Generic Name: bretylium tosylate

Tradenames:4
Patents:0
Applicants:11
NDAs:16
Drug Master File Entries: see list3
Bulk Api Vendors: see list41
Clinical Trials: see list118
Patent Applications: see list1,017
Drug Prices:see low prices
DailyMed Link:bretylium tosylate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
BRETYLIUM TOSYLATE
bretylium tosylate
INJECTABLE;INJECTION070545-001May 14, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
BRETYLIUM TOSYLATE
bretylium tosylate
INJECTABLE;INJECTION019033-001Apr 29, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
B Braun
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
bretylium tosylate
INJECTABLE;INJECTION019121-002Apr 29, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
BRETYLIUM TOSYLATE
bretylium tosylate
INJECTABLE;INJECTION019030-001Apr 29, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
bretylium tosylate
INJECTABLE;INJECTION019837-002Apr 12, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Abraxis Pharm
BRETYLIUM TOSYLATE
bretylium tosylate
INJECTABLE;INJECTION071298-001Feb 13, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca
BRETYLIUM TOSYLATE
bretylium tosylate
INJECTABLE;INJECTION071151-001Aug 10, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Eurohlth Intl Sarl
BRETYLIUM TOSYLATE
bretylium tosylate
INJECTABLE;INJECTION070546-001May 14, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
bretylium tosylate
INJECTABLE;INJECTION019008-003Apr 29, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
BRETYLIUM TOSYLATE IN DEXTROSE 5%
bretylium tosylate
INJECTABLE;INJECTION019005-003Apr 29, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: bretylium tosylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hospira
BRETYLOL
bretylium tosylate
INJECTABLE;INJECTION017954-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Merck
McKinsey
US Department of Justice
Cantor Fitzgerald
Daiichi Sankyo
Novartis
Farmers Insurance
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot